Loading paragraph...
Loading brightcove_video_embed...
Loading paragraph...
Loading paragraph...
Loading ticker_table...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading definition...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading pitch...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading definition...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading paragraph...
Loading paragraph...
Loading hub_pages...
Loading paragraph...
Loading pitch...
Loading paragraph...
Loading faq...

About the Author

Keith Speights
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Quest Diagnostics. The Motley Fool recommends Green Thumb Industries, Innovative Industrial Properties, and Turning Point Brands. The Motley Fool has a disclosure policy.